Results 311 to 320 of about 117,210 (347)
Some of the next articles are maybe not open access.
Current Opinion in Pulmonary Medicine, 1996
Idiopathic pulmonary fibrosis (IPF), or cryptogenic fibrosing alveolitis as it is known in the United Kingdom and Europe, is perhaps one of the most complex and frustrating pulmonary disorders. The cause of this illness is unknown. Treatment often founders in a mire of discontent, dissatisfaction, and failure. In fact, the philosophic homily "If you do
openaire +2 more sources
Idiopathic pulmonary fibrosis (IPF), or cryptogenic fibrosing alveolitis as it is known in the United Kingdom and Europe, is perhaps one of the most complex and frustrating pulmonary disorders. The cause of this illness is unknown. Treatment often founders in a mire of discontent, dissatisfaction, and failure. In fact, the philosophic homily "If you do
openaire +2 more sources
MicroRNAs in idiopathic pulmonary fibrosis
Translational Research, 2011In this review, we describe the recent advances in the understanding of the role of microRNAs in idiopathic pulmonary fibrosis (IPF), a chronic progressive and lethal fibrotic lung disease. Approximately 10% of the microRNAs are significantly changed in IPF lungs.
Kusum V, Pandit +2 more
openaire +2 more sources
[Idiopathic pulmonary fibrosis].
Presse medicale (Paris, France : 1983), 2006Idiopathic pulmonary fibrosis is a chronic disorder characterized histopathologically by a pattern of usual interstitial pneumonia, with heterogeneous and mutilating interstitial fibrosis with foci of proliferating fibroblasts, honeycomb lung, and little if any inflammation.
Cottin, Vincent, Cordier, Jean-François
openaire +3 more sources
Familial Idiopathic Pulmonary Fibrosis
2013Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease of unknown etiology, with an appearance of usual interstitial pneumonia on lung biopsy. To-date, about a 100 families diagnosed with IPF have been described. Familial IPF is defined as histologically confirmed IPF occurring in two or more members of a family.
K, Wytrychowski +2 more
openaire +2 more sources
Pulmonary rehabilitation in idiopathic pulmonary fibrosis
Current Opinion in Pulmonary MedicinePurpose of review This review synthesizes the expanding evidence for pulmonary rehabilitation that has led to its recommended inclusion in the holistic care of people with idiopathic pulmonary fibrosis (IPF), as well as discussing strategies that may maximize and sustain benefits.
Leona M, Dowman, Anne E, Holland
openaire +2 more sources
Idiopathic pulmonary fibrosis in infants
Pediatric Pulmonology, 1997Idiopathic pulmonary fibrosis is a poorly characterized disease in infants. In the present report, we reviewed our experience with 10 infants during a 10-year period. In 9 patients, onset of symptoms occurred before the age of 2 months and included tachypnea, cough, and inadequate weight gain.
E, Osika +8 more
openaire +2 more sources
Biomarkers in idiopathic pulmonary fibrosis
Matrix Biology, 2018Idiopathic pulmonary fibrosis (IPF) is a chronic, debilitating, fibrotic lung disease leading to respiratory failure and ultimately to death. Being the prototype of interstitial lung diseases, IPF is characterized by marked heterogeneity regarding its clinical course.
F, Drakopanagiotakis +3 more
openaire +2 more sources
Treatments for Idiopathic Pulmonary Fibrosis
New England Journal of Medicine, 2014To the Editor: In reporting the results of the INPULSIS-1 and INPULSIS-2 trials, Richeldi et al. (May 29 issue) 1 describe the use of nintedanib in the treatment of idiopathic pulmonary fibrosis. In the same issue, King et al. 2 report the results of the Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis (ASCEND ...
Shinyu, Izumi +2 more
openaire +7 more sources
Treatment of Idiopathic Pulmonary Fibrosis
Seminars in Respiratory and Critical Care Medicine, 2006Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive lung disease in most cases, and effective treatment is still lacking. This review examines the current status of treatment options and complexities in the management of patients with IPF.
Craig E, Daniels, Jay H, Ryu
openaire +2 more sources
Idiopathic pulmonary fibrosis and malignancy
Current Opinion in Pulmonary Medicine, 2001The reported frequency of lung cancer in the setting of diffuse pulmonary fibrosis varies greatly, depending on the country of origin and the type of study. Most recent reports regarding diffuse pulmonary fibrosis in general and idiopathic pulmonary fibrosis in particular and lung cancers come from Japan; only a few clinical studies of this issue are ...
Y, Ma, C K, Seneviratne, M, Koss
openaire +2 more sources